Are granisetron and ondansetron equivalent in the clinic?
- 31 December 1992
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28, S32-S35
- https://doi.org/10.1016/0959-8049(92)90634-e
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Superiority of Granisetron to Dexamethasone Plus Prochlorperazine in the Prevention of Chemotherapy-Induced EmesisJNCI Journal of the National Cancer Institute, 1991
- Methodology of antiemetic trials: A reviewAnnals of Oncology, 1991
- Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and VomitingAnnals of Internal Medicine, 1990
- Ondansetron (GR38032) in the prophylaxis of acute and delayed cisplatin-induced emesisClinical Oncology, 1990
- A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.Journal of Clinical Oncology, 1990
- Ondansetron: a new antiemetic for patients receiving cisplatin chemotherapy.Journal of Clinical Oncology, 1990
- Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced EmesisNew England Journal of Medicine, 1990
- GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis.Journal of Clinical Oncology, 1989
- GR38032F, a 5HT3 receptor antagonist, in the prophylaxis of acute cisplatin-induced nausea and vomitingCancer Chemotherapy and Pharmacology, 1989
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983